Literature DB >> 12853388

C-terminal region of outer surface protein C binds borreliacidal antibodies in sera from patients with Lyme disease.

Dean A Jobe1, Steven D Lovrich, Ronald F Schell, Steven M Callister.   

Abstract

Borreliacidal antibodies specific for outer surface protein C (OspC) are induced shortly after infection with Borrelia burgdorferi. In this study, we identified the region of OspC recognized by immunoglobulin M (IgM) and IgG borreliacidal antibodies. Sera from patients with early Lyme disease were screened for borreliacidal activity specific for B. burgdorferi 50772 and OspC antibodies. Seven sera that contained similarly high titers of each response were then chosen randomly and adsorbed with OspC or a truncated OspC (OspC-Dra) containing the 50 amino acids nearest the carboxy terminus. Adsorption with OspC or OspC-Dra completely eliminated the borreliacidal activity in six (86%) of seven sera and significantly decreased the activity in the remaining serum (titer of 10,240 to 1,280). Moreover, OspC antibodies were no longer detected by OspC enzyme-linked immunosorbent assay or in a Western blot that contained native OspC. The findings confirmed that sera from patients with early Lyme disease contain high concentrations of IgM or IgG borreliacidal antibodies that bind a conserved region of OspC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12853388      PMCID: PMC164245          DOI: 10.1128/cdli.10.4.573-578.2003

Source DB:  PubMed          Journal:  Clin Diagn Lab Immunol        ISSN: 1071-412X


  35 in total

1.  Crystal structure of Lyme disease antigen outer surface protein C from Borrelia burgdorferi.

Authors:  C Eicken; V Sharma; T Klabunde; R T Owens; D S Pikas; M Höök; J C Sacchettini
Journal:  J Biol Chem       Date:  2001-01-03       Impact factor: 5.157

2.  Mutation and recombination in the upstream homology box-flanked ospE-related genes of the Lyme disease spirochetes result in the development of new antigenic variants during infection.

Authors:  S Y Sung; J V McDowell; J A Carlyon; R T Marconi
Journal:  Infect Immun       Date:  2000-03       Impact factor: 3.441

3.  Borreliacidal activity of early Lyme disease sera against complement-resistant Borrelia afzelii FEM1 wild-type and an OspC-lacking FEM1 variant.

Authors:  Peter Kraiczy; Klaus-Peter Hunfeld; Stefan Peters; Reinhard Würzner; Georg Acker; Bettina Wilske; Volker Brade
Journal:  J Med Microbiol       Date:  2000-10       Impact factor: 2.472

4.  Conformational nature of the Borrelia burgdorferi decorin binding protein A epitopes that elicit protective antibodies.

Authors:  N D Ulbrandt; D R Cassatt; N K Patel; W C Roberts; C M Bachy; C A Fazenbaker; M S Hanson
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

5.  Crystal structure of outer surface protein C (OspC) from the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  D Kumaran; S Eswaramoorthy; B J Luft; S Koide; J J Dunn; C L Lawson; S Swaminathan
Journal:  EMBO J       Date:  2001-03-01       Impact factor: 11.598

6.  Evaluation of whole-cell and OspC enzyme-linked immunosorbent assays for discrimination of early lyme borreliosis from OspA vaccination.

Authors:  C A Wieneke; S D Lovrich; S M Callister; D A Jobe; J A Marks; R F Schell
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

7.  Conformational nature of the Borrelia burgdorferi B31 outer surface protein C protective epitope.

Authors:  R D Gilmore; M L Mbow
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

8.  Growth-inhibiting antibody responses of humans vaccinated with recombinant outer surface protein A or infected with Borrelia burgdorferi or both.

Authors:  C J Luke; M A Marshall; J M Zahradnik; M Bybel; B E Menefee; A G Barbour
Journal:  J Infect Dis       Date:  2000-03       Impact factor: 5.226

9.  Specific immune response to a synthetic peptide derived from outer surface protein C of Borrelia burgdorferi predicts protective borreliacidal antibodies.

Authors:  M Ikushima; K Matsui; F Yamada; S Kawahashi; S K Nishikawa
Journal:  FEMS Immunol Med Microbiol       Date:  2000-09

10.  Protection elicited by native outer membrane protein Oms66 (p66) against host-adapted Borrelia burgdorferi: conformational nature of bactericidal epitopes.

Authors:  M M Exner; X Wu; D R Blanco; J N Miller; M A Lovett
Journal:  Infect Immun       Date:  2000-05       Impact factor: 3.441

View more
  17 in total

Review 1.  Diversity of the Lyme Disease Spirochetes and its Influence on Immune Responses to Infection and Vaccination.

Authors:  Jerilyn R Izac; Richard T Marconi
Journal:  Vet Clin North Am Small Anim Pract       Date:  2019-04-06       Impact factor: 2.093

2.  Construction and analysis of variants of a polyvalent Lyme disease vaccine: approaches for improving the immune response to chimeric vaccinogens.

Authors:  Christopher G Earnhart; Richard T Marconi
Journal:  Vaccine       Date:  2007-01-17       Impact factor: 3.641

3.  Analysis of antibody response in humans to the type A OspC loop 5 domain and assessment of the potential utility of the loop 5 epitope in Lyme disease vaccine development.

Authors:  Eric L Buckles; Christopher G Earnhart; Richard T Marconi
Journal:  Clin Vaccine Immunol       Date:  2006-10

4.  Analysis of the antigenic determinants of the OspC protein of the Lyme disease spirochetes: Evidence that the C10 motif is not immunodominant or required to elicit bactericidal antibody responses.

Authors:  Jerilyn R Izac; Andrew C Camire; Christopher G Earnhart; Monica E Embers; Rebecca A Funk; Edward B Breitschwerdt; Richard T Marconi
Journal:  Vaccine       Date:  2019-03-25       Impact factor: 3.641

5.  Enhanced Protective Immunogenicity of Homodimeric Borrelia burgdorferi Outer Surface Protein C.

Authors:  Diane G Edmondson; Sabitha Prabhakaran; Steven J Norris; Amy J Ullmann; Joe Piesman; Marc Dolan; Christian Probst; Christiane Radzimski; Winfried Stöcker; Lars Komorowski
Journal:  Clin Vaccine Immunol       Date:  2017-01-05

6.  [Bilateral reduction in visual acuity with extensive macular edema].

Authors:  M von Wedemeyer; W Wiegand
Journal:  Ophthalmologe       Date:  2016-11       Impact factor: 1.059

7.  Beta2 integrins control the severity of murine Lyme carditis.

Authors:  Mireia Guerau-de-Arellano; Joseph Alroy; Brigitte T Huber
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

8.  Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.

Authors:  Steven D Lovrich; Dean A Jobe; Ronald F Schell; Steven M Callister
Journal:  Clin Diagn Lab Immunol       Date:  2005-06

9.  One-year duration of immunity induced by vaccination with a canine Lyme disease bacterin.

Authors:  Rhonda L LaFleur; Steven M Callister; Jennifer C Dant; Dean A Jobe; Steven D Lovrich; Thomas F Warner; Terri L Wasmoen; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2010-03-17

10.  Bacterin that induces anti-OspA and anti-OspC borreliacidal antibodies provides a high level of protection against canine Lyme disease.

Authors:  Rhonda L LaFleur; Jennifer C Dant; Terri L Wasmoen; Steven M Callister; Dean A Jobe; Steven D Lovrich; Thomas F Warner; O Abdelmagid; Ronald F Schell
Journal:  Clin Vaccine Immunol       Date:  2008-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.